Articlenpj health systems2026
Application of a machine learning model to predict the estimated primary care patient time consumption.
Article in npj health systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Rising healthcare costs and a shortage of primary care providers in the United States create substantial strain on the healthcare system, underscoring the need for efficient allocation of limited resources. Accurate prediction of high primary care utilization can enable proactive care planning, targeted interventions, and workload optimization. We developed and evaluated the Friedman Score, a machine learning-based model that predicts estimated yearly primary care utilization categories, low use (0-85th percentile), High Use (>85-95th percentile), and very High Use (>95th percentile), using structured electronic health record data from UCSD Health primary care patients in 2022-2023. Features included age, chronic disease diagnoses, medication history, and acute care patterns. XGBoost was selected as the primary modeling approach, and its results were benchmarked against five other machine learning algorithms. Across both years, XGBoost consistently demonstrated high discriminative ability (AUC 0.78-0.89 in 2022; 0.81-0.89 in 2023) and robust calibration. SHAP analysis identified medication usage, age, and chronic disease burden, particularly depression, as the most influential predictors. The Friedman Score offers a robust, interpretable tool for identifying high-utilization patients, providing actionable insights to guide proactive, data-driven primary care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.